Reviews push for clearer evidence on functional pet food ingredients

Two new review papers are adding structure to one of the fastest-moving areas in companion animal nutrition: the shift from talking broadly about “functional ingredients” to more specifically evaluating bioactive compounds in commercial pet food. The Veterinary Research Communications review maps a wide range of ingredient categories and links them to eleven health dimensions in dogs and cats, while the Animals review focuses on plant-derived ingredients and the mechanisms by which phytochemicals may influence inflammation, oxidative stress, immunity, metabolism, and the microbiome. (eurekamag.com)

That framing matters because the market has been moving faster than the evidence base for years. Trade coverage has long pointed to growing use of functional claims in pet food as brands look to differentiate formulations with ingredients tied to gut health, skin and coat support, mobility, calming, and healthy aging. At the same time, earlier reviews in the field have argued that success depends on delivering bioactive components in a predictable, safe, and functional manner, rather than simply adding trendy ingredients to a label. (petfoodindustry.com)

The newer Veterinary Research Communications review appears aimed at that gap. According to the available summary, it sets out definitions and classification systems for functional ingredients, bioactive compounds, and dietary supplements in pets, then reviews evidence across digestive health, skin and coat, musculoskeletal health, oral health, behavior and mood, immune regulation, cognitive function, obesity management, cardiovascular regulation, liver protection, and urinary and renal health. The Animals review complements that by organizing plant-derived ingredients by phytochemical class and application form, with particular attention to polyphenols, plant extracts, microalgae, omega-3 sources, and cannabinoids. (eurekamag.com)

What these papers do not do is erase the practical limitations veterinarians see every day. Much of the published evidence around functional ingredients still comes from ingredient-specific studies, short-term trials, or work outside finished commercial diets. Even when mechanistic rationale is strong, translation into a shelf-stable extruded or canned product can be complicated by palatability, processing losses, dose consistency, bioavailability, and interactions with the rest of the formula. Industry reporting and prior reviews have repeatedly noted that formulation execution, not just ingredient selection, determines whether a functional concept is clinically meaningful. (petfoodindustry.com)

There’s also a regulatory reason this conversation matters. FDA’s Center for Veterinary Medicine says pet food claims that imply curing, treating, preventing, or mitigating disease, or affecting structure or function beyond ordinary food purposes, can signal that a product is a new animal drug. AAFCO, meanwhile, distinguishes products that are complete and balanced from those intended for intermittent or supplemental feeding only, and notes that snacks, treats, and supplements are handled differently in labeling. In other words, the stronger the functional claim, the more important the substantiation and regulatory framing become. (fda.gov)

Why it matters: For veterinary teams, these reviews are useful less as endorsements of specific ingredients and more as a roadmap for better questions. What is the active compound? At what dose? In what matrix? In which species, life stage, or disease context? Was the effect shown in a finished diet, a supplement, or an experimental model? And is the claim aligned with what the product can legally and scientifically support? That kind of structured thinking is increasingly important as pet parents encounter more foods, toppers, chews, and supplements marketed around microbiome support, calming, cognition, skin health, and longevity. WSAVA’s nutrition resources likewise emphasize evidence-based nutritional guidance and careful interpretation of pet food information. (wsava.org)

The industry perspective is likely to be mixed but familiar: interest will remain high, especially for microbiome-active ingredients, plant extracts, algae-derived compounds, and other components that fit premiumization and wellness trends. But the bar is rising for reproducible evidence and for claims that can withstand both veterinary scrutiny and regulatory review. That’s especially true as the line between food, supplement, and therapeutic positioning continues to blur in the marketplace. (petfoodprocessing.net)

What to watch: The next phase will likely center on controlled trials in finished commercial diets, more standardized terminology, and closer attention to how companies substantiate claims without crossing into drug territory. (eurekamag.com)